Assignee profile:

PHARNEXT

City:

ISSY LES MOULINEAUX

Country:

France

Published Applications:

50

Last publication date:

2021-08-26

Patent Grants:

46

Last grant date:

2025-02-18

Top Inventors for applications by PHARNEXT

These are the the leading inventors for applications assigned to PHARNEXT:

Recent patent applications by PHARNEXT

PHARNEXT based in ISSY LES MOULINEAUX, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-08-26 βœ… Patent 12,226,413 granted on 2025-02-18
US20210260053A1
Human necessities

Early treatment of CMT disease

#2 | 2020-04-30 βœ… Patent 10,736,876 granted on 2020-08-11
US20200129479A1
Human necessities

Idalopirdine-based combinatorial therapies of Alzheimer's disease

#3 | 2020-01-30 βœ… Patent 10,940,147 granted on 2021-03-09
US20200030314A1
Human necessities

Early treatment of CMT disease

#4 | 2019-09-26 βœ… Patent 10,849,851 granted on 2020-12-01
US20190290578A1
Human necessities

Stable oral solutions for combined API

#5 | 2019-06-13 βœ… Patent 10,682,342 granted on 2020-06-16
US20190175568A1
Human necessities

Compositions for treating amyotrophic lateral sclerosis

#6 | 2019-04-18 βœ… Patent 10,799,499 granted on 2020-10-13
US20190111054A1
Human necessities

Combinatorial therapies of neurological disorders

#7 | 2019-01-10 βœ… Patent 10,596,160 granted on 2020-03-24
US20190008841A1
Human necessities

Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level

#8 | 2018-12-20 βœ… Patent 10,441,558 granted on 2019-10-15
US20180360785A1
Human necessities

Therapeutic approaches for treating CMT and related disorders

#9 | 2018-12-06 βœ… Patent 10,342,784 granted on 2019-07-09
US20180344711A1
Human necessities

Compositions for treating amyotrophic lateral sclerosis

#10 | 2018-11-29 βœ… Patent 10,434,109 granted on 2019-10-08
US20180338988A1
Human necessities

Compositions for treating neurological disorders

#11 | 2018-11-29 βœ… Patent 10,463,640 granted on 2019-11-05
US20180338969A1
Human necessities

Therapeutic approaches for treating CMT and related disorders

#12 | 2018-09-20
US20180263989A1
Human necessities

THERAPEUTIC APPROACHES FOR TREATING PARKINSON'S DISEASE

#13 | 2018-09-06 βœ… Patent 10,905,686 granted on 2021-02-02
US20180250290A1
Human necessities

Compositions for treating CMT and related disorders

#14 | 2018-09-06 βœ… Patent 10,322,101 granted on 2019-06-18
US20180250289A1
Human necessities

Therapeutic approaches for treating CMT and related disorders

#15 | 2018-04-05 βœ… Patent 10,265,304 granted on 2019-04-23
US20180092890A1
Human necessities

Nootropic compositions for improving memory performance

#16 | 2018-01-04 βœ… Patent 10,383,870 granted on 2019-08-20
US20180000813A1
Human necessities

Early treatment of CMT disease

#17 | 2017-09-28 βœ… Patent 10,342,768 granted on 2019-07-09
US20170273919A1
Human necessities

Therapeutic approaches for treating Parkinson's disease

#18 | 2017-06-15 βœ… Patent 10,583,135 granted on 2020-03-10
US20170165256A1
Human necessities

Compositions for treating CMT and related disorders

#19 | 2017-02-23
US20170049777A1
Human necessities

COMPOSITIONS, METHODS AND USES FOR THE TREATMENT OF DIABETIC NEUROPATHIES

#20 | 2016-12-08 βœ… Patent 9,566,275 granted on 2017-02-14
US20160354362A1
Human necessities

Compositions for treating CMT and related disorders

#21 | 2016-12-08 βœ… Patent 10,905,672 granted on 2021-02-02
US20160354335A1
Human necessities

Combination of baclofen, acamprosate and medium chain triglycerides for the treatment of neurological disorders

#22 | 2016-09-15 βœ… Patent 9,427,436 granted on 2016-08-30
US20160263104A1
Human necessities

Compositions for treating CMT and related disorders

#23 | 2016-08-18 βœ… Patent 10,617,689 granted on 2020-04-14
US20160235693A1
Human necessities

Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level

#24 | 2016-07-21 βœ… Patent 9,931,326 granted on 2018-04-03
US20160206603A1
Human necessities

Composition comprising torasemide and baclofen for treating neurological disorders

#25 | 2016-07-07 βœ… Patent 10,010,515 granted on 2018-07-03
US20160193163A1
Human necessities

Therapeutic approaches for treating Parkinson's disease

#26 | 2016-05-19 βœ… Patent 10,045,971 granted on 2018-08-14
US20160136143A1
Human necessities

Compositions for treating amyotrophic lateral sclerosis

#27 | 2016-04-28 βœ… Patent 10,300,015 granted on 2019-05-28
US20160113867A1
Human necessities

Stable oral solutions for combined API

#28 | 2016-01-07 βœ… Patent 9,636,316 granted on 2017-05-02
US20160000736A1
Human necessities

Baclofen and acamprosate based therapy of neurological disorders

#29 | 2015-12-31
US20150374647A1
Human necessities

THERAPEUTIC APPROACHES FOR TREATING EPILEPSY AND RELATED DISORDERS THROUGH REDUCTION OF EPILEPTOGENESIS

#30 | 2015-10-22 βœ… Patent 9,945,876 granted on 2018-04-17
US20150301069A1
Physics

Diagnostic tools for charcot-marie-tooth disease

#31 | 2015-09-03 βœ… Patent 10,004,744 granted on 2018-06-26
US20150246044A1
Human necessities

Therapeutic approaches for treating Parkinson's disease

#32 | 2015-08-27 βœ… Patent 9,545,389 granted on 2017-01-17
US20150238452A1
Human necessities

Baclofen and acamprosate based therapy of macular degeneration disorders

#33 | 2015-08-20 βœ… Patent 10,092,554 granted on 2018-10-09
US20150231123A1
Human necessities

Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level

#34 | 2015-08-13 βœ… Patent 9,789,098 granted on 2017-10-17
US20150224092A1
Human necessities

Nootropic compositions for improving memory performance

#35 | 2014-12-25 βœ… Patent 9,144,558 granted on 2015-09-29
US20140378440A1
Human necessities

Baclofen and acamprosate based therapy of neurological disorders

#36 | 2014-12-18 βœ… Patent 9,241,933 granted on 2016-01-26
US20140371277A1
Human necessities

Compositions for treating amyotrophic lateral sclerosis

#37 | 2014-12-18 βœ… Patent 9,248,111 granted on 2016-02-02
US20140371229A1
Human necessities

Therapeutic approaches for treating parkinson's disease

#38 | 2014-12-04 βœ… Patent 9,387,206 granted on 2016-07-12
US20140357648A1
Human necessities

Therapeutic approaches for treating Alzheimer's disease

#39 | 2014-08-21 βœ… Patent 9,597,297 granted on 2017-03-21
US20140235599A1
Human necessities

Combination of pilocarpin and methimazol for treating Charcot-Marietooth disease and related disorders

#40 | 2014-06-26 βœ… Patent 9,393,241 granted on 2016-07-19
US20140178463A1
Human necessities

Compositions for treating CMT and related disorders

#41 | 2014-03-20 βœ… Patent 9,820,978 granted on 2017-11-21
US20140080873A1
Human necessities

Treatment of cerebral ischemia

#42 | 2014-02-06 βœ… Patent 9,867,837 granted on 2018-01-16
US20140038927A1
Human necessities

Compositions for treating neurological disorders

#43 | 2013-08-22 βœ… Patent 9,494,605 granted on 2016-11-15
US20130217036A1
Physics

Diagnostic tools for charcot-marie-tooth disease

#44 | 2013-04-11 βœ… Patent 8,741,886 granted on 2014-06-03
US20130090307A1
Human necessities

Baclofen and acamprosate based therapy of neurological disorders

#45 | 2013-04-04 βœ… Patent 8,865,769 granted on 2014-10-21
US20130085122A1
Human necessities

Baclofen and acamprosate based therapy of neurological disorders

#46 | 2012-11-08 βœ… Patent 9,493,834 granted on 2016-11-15
US20120283114A1
Chemistry; metallurgy

Method for detecting a panel of biomarkers

#47 | 2012-10-25 βœ… Patent 8,809,302 granted on 2014-08-19
US20120270836A1
Human necessities

Therapeutic approaches for treating alzheimer'S disease

#48 | 2012-05-03 βœ… Patent 8,642,566 granted on 2014-02-04
US20120108528A1
Human necessities

Therapeutic approaches for treating neuroinflammatory conditions

#49 | 2012-04-12
US20120088744A1
Human necessities

COMPOSITIONS FOR TREATING CMT AND RELATED DISORDERS

#50 | 2012-02-16 βœ… Patent 8,716,269 granted on 2014-05-06
US20120040940A1
Human necessities

Combination of pilocarpin and methimazol for treating Charcot-Marietooth disease and related disorders

Also check out Pharnext's (Issy les Moulineaux, France) applicant profile with 40 patent applications submitted.

AssigneeID:

16916 ⎘